References
- Morrison VA Haake RJ Weisdorf DJ Non-Candida fungal infections after bone marrow transplantation: risk fac-tors and outcome. Arn J Med (1994) 96(0:497–503
- Smith GH. Treatment of infections in the patient with acquired immunodeficiency syndrome. Arch Intern Med (1994) 154(9):949–73
- Bodey GP Anaissie EJ Elting IS Estey E O'Brien S ICantarjianH. Antifungal prophylaxis during remission induction therapy for acute leukemia fruconazole versus intrave-nous amphotericin B. Cancer(1994) 73(8):2099–106.
- Schmatz DM Abruzzo G Powles MA McFadden DC Balkovec JM Black RM, Nollstadt K Banizal K. Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural, and semisynthetic pneumocandins for activity against Pneuntocystis carinii and Candida species. J Antibiot (Tokyo) (1992) 45(12):1886–91.
- Moore KS Wehrli S Roder H Rogers M Forrest JN Jr McCrim-mon D. Zasloff M. Squalamine: an aminosterol antibiotic from the shark. Proc NatlAcad Sci USA (1993) 90(4):1354–8.
- Dickinson K Keer V Hitchcock CA Adams DJ. Chitinase activity from Candida albicans and its inhibition by allosamidin. J Gen Microbic) (1989) 135 (6):1417–21.
- Brill GM Chen RH Rasmussen RR Whittem DN McAlpine JB. Calbistrins, novel antifungal agents produced by Penicillium restrictum. IL Isolation and elucidation of structure. J Antibiot (Tokyo) (1993) 46(039–47.
- Jackson M Karwowski JP Humphrey PE Kohl WL Barlow GJ Tanaka SK. Calbistrins, novel antifungal agents pro-duced by Petticillium restticium. L Production, taxon-omy of the producing organism and biological activity. J Antibiot (Tokyo) (1993) 46(1):34–8.